Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine
Historical observation
20182026
Universe›Health Care›Biotechnology›Biotechnology
Biotechnology · weight
2.84%
Industry change · 12M
-0.58 pp
Biotechnology · contribution
-0.582 pp
Company participation
100%
of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Feb 2019 · sorted by absolute contribution to 12-month change

CompanyCountryMarket capUniverse weight3M contribution12M contribution12M price returnAbove 6M weight average
AbbVie →
ABBV
United States$116.9bn0.678%+0.206 pp-0.425 pp-28.6%Yes
Gilead Sciences →
GILD
United States$82.9bn0.481%+0.172 pp-0.137 pp-14.8%Yes
Amgen →
AMGN
United States$118.3bn0.686%+0.245 pp-0.108 pp+6.5%Yes
Regeneron Pharmaceuticals →
REGN
United States$40.5bn0.235%+0.120 pp+0.054 pp+34.4%Yes
Vertex Pharmaceuticals →
VRTX
United States$48.3bn0.280%+0.126 pp+0.027 pp+13.7%Yes
Biogen →
BIIB
United States$64.5bn0.374%+0.151 pp+0.008 pp+13.5%Yes
Incyte →
INCY
United States$18.5bn0.107%+0.062 pp-0.001 pp+1.3%Yes

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.